Approval Progress for Novel-Mechanism and Nucleic Acid Drugs
A market-environment theme focused on the advancing approval track record in Japan and overseas for drugs using new mechanisms of action and technologies, including nucleic acid drugs, novel-mechanism drugs and CAR-T cell therapies.
Companies2How many companies write about this.
Threads2One company can carry more than one thread here.